{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:31:30Z","timestamp":1772224290530,"version":"3.50.1"},"reference-count":126,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,11,23]],"date-time":"2002-11-23T00:00:00Z","timestamp":1038009600000},"content-version":"vor","delay-in-days":267,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The newly developed immunomodulator tacrolimus (FK506) is the first of a new class of agents that have enormous potential to change the way that dermatoses are treated and managed. Tacrolimus has been found to be active in a topical formulation with the latter exerting its effects by acting on the signal transduction pathways inside T cells and inhibiting gene transcription. The result is decreased responsiveness of T cells to antigens. Percutaneous absorption of tacrolimus is higher in diseased skin as opposed to healthy skin and, therefore, the drug will be taken in at progressively lower quantities as lesions heal. There is limited systemic absorption of tacrolimus over the course of therapy. The most extensive experience with tacrolimus has been in treating atopic dermatitis. In numerous trials, tacrolimus ointment 0.03\u20130.3% has shown to be effective in reducing the symptoms and severity of atopic dermatitis in adults and the paediatric population. Furthermore, there have been no significant toxic effects associated with topical therapy with tacrolimus. The most common complaint is that of local irritation after applying the ointment. This is generally transient and the patient is able to continue with therapy. The other dermatoses where tacrolimus has been used include contact dermatitis, psoriasis and pyoderma gangrenosum.<\/jats:p>","DOI":"10.1046\/j.1468-3083.2002.00380.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T04:42:02Z","timestamp":1047444122000},"page":"100-114","source":"Crossref","is-referenced-by-count":62,"title":["Tacrolimus: a review of its use for the management of dermatoses"],"prefix":"10.1111","volume":"16","author":[{"given":"AK","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Adamiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,11,23]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.5.574"},{"key":"e_1_2_10_3_2","first-page":"74","article-title":"Tacrolimus (FK506): experience in dermatology","volume":"5","author":"Lawrence ID.","year":"1998","journal-title":"Dermatol Ther"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(96)80599-8"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70055-2"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-60752-3_5"},{"key":"e_1_2_10_7_2","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.4049\/jimmunol.154.11.6058","article-title":"Human skin mast cells express functional beta1 integrins that mediate adhesion to extracellular martix proteins","volume":"154","author":"Columbo M","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.112600"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.113521"},{"key":"e_1_2_10_10_2","first-page":"321","article-title":"FK\u2010506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice","volume":"283","author":"Nagai H","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_10_11_2","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.4049\/jimmunol.160.11.5331","article-title":"Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses","volume":"160","author":"Homey B","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.109815"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2000.00698.x"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1542\/pir.20-2-46"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555924447"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s3009.x"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s3013.x"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s3017.x"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-199612050-00003"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70051-5"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s000110050500"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12614216"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70272-1"},{"key":"e_1_2_10_24_2","first-page":"Abstract 654","article-title":"Topical triamcinolone and tacrolimus differ in their in vivo effects on Langerhans cells during the treatment of atopic dermatitis","volume":"11","author":"Gordon K","year":"1999","journal-title":"J Invest Dermatol"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.112942"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb17158.x"},{"key":"e_1_2_10_27_2","first-page":"3330","article-title":"Influence of FK506 on T lymphocytes, Langerhans\u2019 cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions: a preliminary study","volume":"23","author":"Thomson AW","year":"1991","journal-title":"Transplant Proc"},{"key":"e_1_2_10_28_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2340\/0001555576357360","article-title":"Soluble interleukin\u2010 2 receptor (sIL\u20102R) is a marker of disease activity in psoriasis: a comparison of sIL\u20102R, sCD27, sCD4, sCD8 and SICAM\u20101","volume":"76","author":"De Rie MA","year":"1996","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"e_1_2_10_29_2","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.4049\/jimmunol.151.8.4399","article-title":"Increased expression of epidermal IL\u20108 receptor in psoriasis; down\u2010regulation by FK\u2010506 in vitro","volume":"151","author":"Schultz BS","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_10_30_2","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.139.6.1797","article-title":"Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation","volume":"139","author":"Sawada S","year":"1987","journal-title":"J Immunol"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1995.tb05525.x"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(96)00039-1"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70270-2"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709183371203"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70541-9"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70410-X"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000211510"},{"key":"e_1_2_10_38_2","first-page":"96","article-title":"Use of the newer immunosuppressive agents in dermatology","volume":"8","author":"Laurema AI","year":"1997","journal-title":"Bio Drugs"},{"key":"e_1_2_10_39_2","first-page":"1196","article-title":"Pharmacokinetics of intra\u2010arterial delivery of tacrolimus to vascularly isolated rabbit forelimb","volume":"289","author":"Shirbacheh MV","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0192-0561(98)00049-6"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702588"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.12968\/hosp.1999.60.5.1118"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/6.1.93"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00911.x"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0363-5023(05)80064-4"},{"key":"e_1_2_10_46_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5223(19)33840-1","article-title":"Prolonged lung allograft survival with a short course of FK506","volume":"105","author":"Hirai T","year":"1993","journal-title":"J Thorac Cardiovasc Surg"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)02062-0"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhsu.1999.0586"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0007-1226(93)90047-F"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1999.00760.x"},{"key":"e_1_2_10_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700716"},{"key":"e_1_2_10_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70162-4"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.3.986"},{"key":"e_1_2_10_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702016"},{"key":"e_1_2_10_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.5.1342"},{"key":"e_1_2_10_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1995.tb03612.x"},{"key":"e_1_2_10_57_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199904010-00003"},{"key":"e_1_2_10_58_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.104.1.309"},{"key":"e_1_2_10_59_2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archderm.1992.01680160065005","article-title":"Tacrolimus (FK506) \u2013 A new therapeutic agent for severe recalcitrant psoriasis","volume":"128","author":"Jegasothy BV","year":"1992","journal-title":"Arch Dermatol"},{"key":"e_1_2_10_60_2","first-page":"3328","article-title":"Efficacy of FK506 in the treatment of recalcitrant pyoderma gangrenosum","volume":"23","author":"Abu\u2010Elmagd K","year":"1991","journal-title":"Transplant Proc"},{"key":"e_1_2_10_61_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.109810"},{"key":"e_1_2_10_62_2","first-page":"Abstract 681","article-title":"Tacrolimus ointment (TO) for adults with moderate to severe atopic dermatitis (AD): a dose escalation study","volume":"110","author":"Kang S","year":"1998","journal-title":"J Invest Dermatol"},{"key":"e_1_2_10_63_2","first-page":"Abstract 681","article-title":"Double\u2010blind hydrocortisone\u2010controlled tacrolimus ointment for atopic dermatitis","volume":"110","author":"Gutgesell C","year":"1998","journal-title":"J Invest Dermatol"},{"key":"e_1_2_10_64_2","unstructured":"NakagawaH EtohT IshibashiYet al.Effects of tacrolimus (FK506) ointment for facial atopic dermatitis 761\u2013764. Madrid Spain 24 June 1995. XVI European Congress of Allergology and Clinical Immonology Conference Proceeding 1995."},{"key":"e_1_2_10_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb02691.x"},{"key":"e_1_2_10_66_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.109814"},{"key":"e_1_2_10_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70281-7"},{"key":"e_1_2_10_68_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.109813"},{"key":"e_1_2_10_69_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.109812"},{"key":"e_1_2_10_70_2","first-page":"867","article-title":"Topical therapies and medications in the pediatric patient","volume":"47","author":"Walker Metry D","year":"2000","journal-title":"Pediatr Dermatol"},{"key":"e_1_2_10_71_2","first-page":"Abstract 680","article-title":"Use of tacrolimus ointment (TO) in 3\u20106 year olds with atopic dermatitis (AD): Dose\u2010escalation study","volume":"110","author":"Hanifin JM","year":"1998","journal-title":"J Invest Dermatol"},{"key":"e_1_2_10_72_2","unstructured":"Package Insert.Protopic (Tacrolimus).Fujisawa Healthcare Inc. Deerfield IL December 2000."},{"key":"e_1_2_10_73_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.8.999"},{"key":"e_1_2_10_74_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.12799.x"},{"key":"e_1_2_10_75_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.112131"},{"key":"e_1_2_10_76_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247133"},{"key":"e_1_2_10_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91757-Y"},{"key":"e_1_2_10_78_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12456939"},{"key":"e_1_2_10_79_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12371737"},{"key":"e_1_2_10_80_2","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.76.175"},{"key":"e_1_2_10_81_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02927.x"},{"key":"e_1_2_10_82_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.9.1101"},{"key":"e_1_2_10_83_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2000.00731.x"},{"key":"e_1_2_10_84_2","first-page":"7","article-title":"Tacrolimus (FK506): Topical inflammatory cytokine inhibitor","author":"Bos JD","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"e_1_2_10_85_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.114739"},{"key":"e_1_2_10_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90234-2"},{"key":"e_1_2_10_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90149-X"},{"key":"e_1_2_10_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)78962-5"},{"key":"e_1_2_10_89_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02746.x"},{"key":"e_1_2_10_90_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.1.105"},{"key":"e_1_2_10_91_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02672.x"},{"key":"e_1_2_10_92_2","first-page":"419","article-title":"Successful treatment of erosive lichen planus with topical tacrolimus","volume":"137","author":"Lener EV","year":"2001","journal-title":"Arch Dermatol"},{"key":"e_1_2_10_93_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12371755"},{"key":"e_1_2_10_94_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12606018"},{"key":"e_1_2_10_95_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1997.tb03777.x"},{"key":"e_1_2_10_96_2","first-page":"1433","article-title":"Hair growth modulation by topical immunophilin ligands; induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy\u2010induced alopecia","volume":"150","author":"Maurer M","year":"1997","journal-title":"Am J Pathol"},{"key":"e_1_2_10_97_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.1.124"},{"key":"e_1_2_10_98_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/14.1.67"},{"key":"e_1_2_10_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(94)90317-4"},{"key":"e_1_2_10_100_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199709270-00023"},{"key":"e_1_2_10_101_2","first-page":"1387","article-title":"Topical immunosuppression in skin grafting with FK506 ointment","volume":"28","author":"Yuzawa K","year":"1996","journal-title":"Transplant Proc"},{"key":"e_1_2_10_102_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.3.436"},{"key":"e_1_2_10_103_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.12.3746.bloodjournal85123746"},{"key":"e_1_2_10_104_2","first-page":"334","article-title":"Nephrotoxicity of FK\u2010506 in the rat. Studies on glomerular and tubular function, and on the relationship between efficacy and toxicity","volume":"10","author":"Nielsen FT","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_10_105_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2000.00628.x"},{"key":"e_1_2_10_106_2","unstructured":"Compendium of Pharmaceuticals Specialties 35th edn.Webcom Limited Toronto 2000:1287\u20131292."},{"key":"e_1_2_10_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/0955-470X(95)80026-5"},{"key":"e_1_2_10_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70203-3"},{"key":"e_1_2_10_109_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970915)80:6<1141::AID-CNCR18>3.0.CO;2-8"},{"key":"e_1_2_10_110_2","doi-asserted-by":"publisher","DOI":"10.1080\/109158198226044"},{"key":"e_1_2_10_111_2","doi-asserted-by":"publisher","DOI":"10.1080\/109158199225765"},{"key":"e_1_2_10_112_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199702000-00016"},{"key":"e_1_2_10_113_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.109817"},{"key":"e_1_2_10_114_2","unstructured":"EtohT.Long\u2010term safety and efficacy of tacrolimus ointment: the Japanese experience.Immunomodulation in Focus Conference Newsletter2000;4\u20135."},{"key":"e_1_2_10_115_2","unstructured":"RustinM.Treatment of atopic dermatitis in adults with topical tacrolimus.Immunomodulation in Focus Conference Newsletter2000;6."},{"key":"e_1_2_10_116_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00323.x"},{"key":"e_1_2_10_117_2","unstructured":"JaraczE FleischerA RicoMJet\u00a0al. Tacrolimus ointment for the treatment of atopic dermatitis: Focus on cutaneous infections.2001.Washington DC. Conference Proceeding."},{"key":"e_1_2_10_118_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018497"},{"key":"e_1_2_10_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)01917-4"},{"key":"e_1_2_10_120_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.10.5037"},{"key":"e_1_2_10_121_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02554.x"},{"key":"e_1_2_10_122_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12345542"},{"key":"e_1_2_10_123_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00567.x"},{"key":"e_1_2_10_124_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)61055-0"},{"key":"e_1_2_10_125_2","first-page":"1","article-title":"Tacrolimus: a promising new therapy for eczema\/atopic dermatitis","volume":"11","author":"McAlister RO.","year":"1999","journal-title":"Advocate"},{"key":"e_1_2_10_126_2","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.59.870"},{"key":"e_1_2_10_127_2","first-page":"277","article-title":"Phase III comparative study on FK506 ointment and aclometasone diproprionate ointment in the treatment of atopic dermatitis","volume":"92","author":"FK506 Ointment Study Group.","year":"1997","journal-title":"Acta Dermatol"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1468-3083.2002.00380.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1468-3083.2002.00380.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T11:22:21Z","timestamp":1697541741000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1468-3083.2002.00380.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":126,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["10.1046\/j.1468-3083.2002.00380.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1468-3083.2002.00380.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}